Abstract
Diabetes mellitus (DM) is a group of metabolic disorders characterized by hyperglycemia. In particular, type 2 diabetes (T2D) represents one of the main causes of death in the world, and those suffering from it have a lower quality of life. Although there are multiple hypotheses about the pathophysiological mechanisms that lead to the development of T2D, the effects of this pathology on pancreatic β-cells are often ignored. We now know that in addition to genetic defects, β-cell organellar dysfunction participates in the earliest stages of the disease; other factors also contribute to this dysfunction, such as excessive production of reactive oxygen species and a decrease in cellular volume and mass. These features usually result from increased apoptosis, which is not adequately compensated for by the characteristic regeneration mechanisms of these cells. In this study, we specifically examine the genetic, epigenetic and metabolic defects that contribute to β-cell dysfunction and lead to the establishment of T2D, particularly the dysregulated insulin synthesis and secretion in these cells.
Keywords: Type 2 diabetes, genetic defects, hyperglycemia, insulin, organellar dysfunction, pancreatic β-cells.
Current Diabetes Reviews
Title:Pancreatic β-Cells and Type 2 Diabetes Development
Volume: 13 Issue: 2
Author(s): Miranda-Perez Maria Elizabeth, Alarcon-Aguilar, Francisco J., Ortega-Camarillo Clara, Escobar-Villanueva and Maria Del Carmen
Affiliation:
Keywords: Type 2 diabetes, genetic defects, hyperglycemia, insulin, organellar dysfunction, pancreatic β-cells.
Abstract: Diabetes mellitus (DM) is a group of metabolic disorders characterized by hyperglycemia. In particular, type 2 diabetes (T2D) represents one of the main causes of death in the world, and those suffering from it have a lower quality of life. Although there are multiple hypotheses about the pathophysiological mechanisms that lead to the development of T2D, the effects of this pathology on pancreatic β-cells are often ignored. We now know that in addition to genetic defects, β-cell organellar dysfunction participates in the earliest stages of the disease; other factors also contribute to this dysfunction, such as excessive production of reactive oxygen species and a decrease in cellular volume and mass. These features usually result from increased apoptosis, which is not adequately compensated for by the characteristic regeneration mechanisms of these cells. In this study, we specifically examine the genetic, epigenetic and metabolic defects that contribute to β-cell dysfunction and lead to the establishment of T2D, particularly the dysregulated insulin synthesis and secretion in these cells.
Export Options
About this article
Cite this article as:
Elizabeth Maria Miranda-Perez, Alarcon-Aguilar , J. Francisco, Clara Ortega-Camarillo, Escobar-Villanueva and Carmen Del Maria, Pancreatic β-Cells and Type 2 Diabetes Development, Current Diabetes Reviews 2017; 13 (2) . https://dx.doi.org/10.2174/1573399812666151020101222
DOI https://dx.doi.org/10.2174/1573399812666151020101222 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Dexamethasone and Restenosis After Coronary Stent Implantation: New Indication for an Old Drug?
Current Pharmaceutical Design SUMOylation in Neurological Diseases
Current Molecular Medicine Human Amniotic Membrane: Clinical Uses, Patents And Marketed Products
Recent Patents on Regenerative Medicine Inflammatory Biomarkers Predicting Events in Atherosclerosis
Current Medicinal Chemistry Reverse Ayurvedic Pharmacology of Ashwagandha as an Adaptogenic Anti-Diabetic Plant: A Pilot Study
Current Traditional Medicine A Review on Electrocardiographic Changes in Diabetic Patients
Current Diabetes Reviews The Involvement of Uric Acid in the Pathogenesis of Preeclampsia
Current Hypertension Reviews Citrobacter braakii Bacteremia: Case Report and Review of the Literature
Infectious Disorders - Drug Targets Bariatric Surgery: Indications, Safety and Efficacy
Current Pharmaceutical Design The Coronary Collateral Circulation in Man
Current Cardiology Reviews Hypertensive Heart Disease and the Role of Aldosterone Antagonists
Current Hypertension Reviews Editorial (Alzheimer’s Disease and Frail Syndrome: Features Overlap Predictive of Poor Outcome)
CNS & Neurological Disorders - Drug Targets Mediterranean Diet, Brain and Muscle: Olive Polyphenols and Resveratrol Protection in Neurodegenerative and Neuromuscular Disorders
Current Medicinal Chemistry Current Trends in Enzyme Inhibition and Docking Analysis in Drug Design-Part -II
Current Topics in Medicinal Chemistry Recent Progress in Biological Activities of Indole and Indole Alkaloids
Mini-Reviews in Medicinal Chemistry Metal Complexes of Biologically Active Ligands as Potential Antioxidants
Current Medicinal Chemistry Anti-IL-1 β Therapies
Recent Patents on DNA & Gene Sequences Hypertension in Type 2 Diabetes Mellitus: Do We Need to Redefine the Role of Sulfonylureas?
Recent Advances in Cardiovascular Drug Discovery (Discontinued) Chronic Kidney Disease and Cardiovascular Disease: A Focus on Primary Care
Cardiovascular & Hematological Disorders-Drug Targets Chromium-Picolinate Therapy in Diabetes Care: Individual Outcomes Require New Guidelines and Navigation by Predictive Diagnostics
Infectious Disorders - Drug Targets